The FDA has approved maribavir for the treatment of adults and pediatric patients aged 12 years or older and weighing at least 35 kg with post-transplant cytomegalovirus infection/disease that is refractory to treatment with ganciclovir, valganciclovir, cidofovir, or foscarnet.
Read More
Whole-Cell Vaccines Could Fight Urinary Tract Infections, Especially Reoccurring
November 24th 2021Investigators have developed an encapsulated and immobilized individual bacterium cell in crystalline polymeric matric that not only kills the bacterium but preserves and stabilizes the dead cell against high temperature, moisture, and organic solvents. The method utilizes metal-organic frameworks (MOFs).
Read More
Expert: During the Nursing Staffing Crisis, ‘Pharmacists Have Been a Godsend’ for Nurses
November 23rd 2021Rita Wise, DEd, MSN, RN, program director of the Masters in Nursing Education and Nursing Administration programs at Pennsylvania College of Health Sciences, discusses her hopes for how the country and health systems will respond to the national nurse staffing crisis.
Watch